data_1iy3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1iy3 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.415 ' HD3' ' CE2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 120.969 0.414 . . . . 3.1699999999999999 110.551 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.4 t -80.32 87.0 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.49 -0.756 . . . . 2.4500000000000002 109.474 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.587 ' CG ' ' HG2' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -94.57 -169.38 2.02 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.368 -0.832 . . . . 3.25 110.735 -179.673 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -100.63 -172.04 2.12 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.494 -0.754 . . . . 2.0600000000000001 111.388 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.543 ' HG2' ' HE2' ' A' ' 29' ' ' MET . 4.3 ttp180 -72.13 -47.35 51.76 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.643 -0.661 . . . . 3.21 111.485 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.61 -36.2 78.03 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.402 -0.811 . . . . 1.04 111.298 -179.047 -128.037 -45.201 163.603 104.246 2.024 105.062 29.23 -170.711 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.587 ' HG2' ' CG ' ' A' ' 3' ' ' PHE . 8.1 tp10 -60.17 -44.53 94.95 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.293 -0.88 . . . . 2.6499999999999999 109.497 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.497 ' HB3' ' HG2' ' A' ' 29' ' ' MET . 0.0 OUTLIER -56.15 -39.05 71.7 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.881 -0.512 . . . . 1.1200000000000001 110.166 179.301 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.418 ' CB ' ' SD ' ' A' ' 29' ' ' MET . . . -58.64 -50.89 72.19 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.43 -0.794 . . . . 1.1599999999999999 110.306 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -73.51 -31.52 63.75 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.535 -0.728 . . . . 3.7400000000000002 110.481 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -60.03 -48.93 79.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.611 -0.681 . . . . 1.8700000000000001 109.91 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.445 ' HB3' ' HB2' ' A' ' 17' ' ' MET . 86.6 mt -72.61 -33.61 66.81 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.486 -0.759 . . . . 1.21 109.863 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -67.4 -37.98 83.95 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.397 -0.814 . . . . 3.2000000000000002 109.644 178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 -62.7 -35.64 80.36 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.682 -0.637 . . . . 2.5099999999999998 109.831 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.464 ' CD2' ' N ' ' A' ' 15' ' ' LEU . 1.4 mm? -79.43 -30.82 42.43 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.689 -0.632 . . . . 1.1799999999999999 110.323 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.36 13.38 9.83 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.3 -1.12 . . . . 0.69999999999999996 110.3 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.445 ' HB2' ' HB3' ' A' ' 12' ' ' LEU . 3.4 mmt -78.71 -19.64 51.96 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.137 -1.214 . . . . 3.3199999999999998 110.84 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -58.02 106.96 0.41 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.452 -0.78 . . . . 2.1800000000000002 110.377 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.4 46.07 21.58 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.434 -1.067 . . . . 0.69999999999999996 110.434 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -108.38 146.24 33.33 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.204 -1.174 . . . . 2.4300000000000002 110.899 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.504 ' HD3' ' HA ' ' A' ' 101' ' ' ARG . 0.1 OUTLIER 58.72 24.48 12.27 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.94 -0.475 . . . . 3.5099999999999998 111.923 179.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.95 -17.22 47.54 Favored Glycine 0 N--CA 1.495 2.627 0 O-C-N 120.988 -1.07 . . . . 0.89000000000000001 110.767 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.444 HD13 ' HB ' ' A' ' 106' ' ' ILE . 4.6 mt -93.65 156.05 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.089 -1.242 . . . . 1.3899999999999999 109.774 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.9 p -105.82 158.42 16.76 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.591 -0.693 . . . . 1.8400000000000001 110.374 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.554 ' HB3' HG11 ' A' ' 125' ' ' VAL . 0.3 OUTLIER -57.31 -30.81 65.06 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.541 -0.725 . . . . 1.8300000000000001 110.456 179.4 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.542 ' HB3' ' HA ' ' A' ' 122' ' ' ARG . . . -50.36 -44.49 54.67 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.808 -0.557 . . . . 1.25 110.224 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.447 ' HA ' HG21 ' A' ' 121' ' ' VAL . 1.6 m120 -74.35 -32.85 62.93 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.617 -0.677 . . . . 1.78 109.652 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.472 ' CZ2' HG11 ' A' ' 100' ' ' VAL . 18.3 m95 -70.05 -39.65 75.58 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.642 -0.661 . . . . 3.52 110.431 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.664 ' HE1' ' HB3' ' A' ' 124' ' ' TYR . 2.3 mtp -74.28 -40.13 62.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.362 -0.836 . . . . 2.0699999999999998 110.823 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.98 -28.99 69.41 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.408 -0.807 . . . . 1.3999999999999999 110.032 179.552 91.668 121.021 170.747 104.058 2.02 104.098 -157.114 -86.932 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 112' ' ' TRP . 24.6 tp -76.66 -44.77 32.51 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.431 -0.793 . . . . 1.6000000000000001 109.641 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.15 -26.83 63.19 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.664 -0.647 . . . . 1.27 110.656 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.409 ' HB2' ' OH ' ' A' ' 38' ' ' TYR . 21.9 tttt -61.37 -48.62 80.42 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.594 -0.691 . . . . 2.6099999999999999 110.819 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -90.24 -23.14 21.32 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.55 -0.719 . . . . 3.5600000000000001 110.548 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.29 -52.1 30.75 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.49 -0.756 . . . . 2.3199999999999998 110.134 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.442 ' HB3' ' CB ' ' A' ' 42' ' ' ALA . 61.7 m -141.75 7.08 1.86 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.601 -0.687 . . . . 1.98 111.783 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.25 50.65 63.01 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.313 -1.515 . . . . 0.81999999999999995 109.313 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.556 ' HA ' HD13 ' A' ' 56' ' ' ILE . 21.7 m-85 52.77 44.27 30.44 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.884 -0.774 . . . . 2.8799999999999999 110.435 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.484 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 43.9 t30 -123.5 120.24 32.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.37 -0.831 . . . . 1.24 110.123 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 14.1 m -75.85 -40.72 54.17 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.458 -0.776 . . . . 1.47 109.323 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.3 mtp180 -66.59 -13.97 61.78 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.817 -0.552 . . . . 3.5899999999999999 111.498 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.484 ' HB2' ' HB3' ' A' ' 39' ' ' ASN . . . -58.86 125.43 23.52 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.27 -0.894 . . . . 1.1699999999999999 110.583 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.494 HG22 ' HA ' ' A' ' 54' ' ' TYR . 26.1 p -143.72 136.34 27.18 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.613 -0.679 . . . . 1.1599999999999999 110.445 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.543 ' HB3' ' HB2' ' A' ' 53' ' ' ASP . 2.4 t30 -99.95 160.58 14.21 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.429 -0.794 . . . . 2.2599999999999998 109.638 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.629 ' HA ' HG21 ' A' ' 52' ' ' THR . 7.3 m-85 -117.08 178.35 4.39 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.425 -0.797 . . . . 5.8799999999999999 110.914 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.6 ' HB2' ' HB2' ' A' ' 49' ' ' ASP . 5.2 p30 -134.03 156.41 48.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.691 -0.631 . . . . 2.7000000000000002 110.527 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.14 80.25 1.3 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.526 -0.734 . . . . 3.54 110.195 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.9 35.21 25.26 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.31 -1.116 . . . . 3.1800000000000002 110.31 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.6 ' HB2' ' HB2' ' A' ' 46' ' ' ASN . 24.5 m-20 -121.27 -12.52 8.63 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.369 -1.077 . . . . 4.6600000000000001 111.181 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER 60.21 31.05 20.36 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.557 -0.715 . . . . 6.21 111.035 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.7 p -136.18 89.35 2.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.456 -0.777 . . . . 2.6400000000000001 109.521 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.629 HG21 ' HA ' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -95.69 128.4 42.54 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.527 -0.733 . . . . 2.2400000000000002 109.84 -179.487 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.543 ' HB2' ' HB3' ' A' ' 44' ' ' ASN . 13.1 m-20 -77.28 127.94 33.46 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.536 -0.727 . . . . 1.4199999999999999 109.983 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.494 ' HA ' HG22 ' A' ' 43' ' ' THR . 4.3 m-85 -134.69 124.2 24.91 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.608 -0.682 . . . . 3.8399999999999999 110.438 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 84' ' ' LEU . . . 121.98 170.12 13.71 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.967 -1.111 . . . . 0.65000000000000002 111.249 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.556 HD13 ' HA ' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -65.8 -26.58 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.951 -0.734 . . . . 2.2000000000000002 110.891 179.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -98.36 14.35 28.34 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.301 -0.874 . . . . 3.6200000000000001 111.031 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.542 ' HB3' ' CZ2' ' A' ' 109' ' ' TRP . 0.8 OUTLIER 50.18 81.7 0.06 Allowed 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.523 -0.735 . . . . 3.1800000000000002 110.704 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.532 HG23 ' SG ' ' A' ' 95' ' ' CYS . 9.1 mt -106.65 116.98 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.151 -0.968 . . . . 1.99 110.286 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -60.47 153.82 22.22 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.65 -0.656 . . . . 2.96 111.144 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.2 t -95.7 21.85 7.91 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.571 -0.705 . . . . 1.6000000000000001 111.359 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 9.0 ttp180 -115.5 -22.75 9.12 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.957 -1.089 . . . . 3.5499999999999998 111.294 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.94 3.38 4.87 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.969 -1.082 . . . . 3.3399999999999999 111.845 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.403 ' CH2' ' HA ' ' A' ' 99' ' ' VAL . 25.8 m95 -127.97 -53.62 1.31 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.948 -1.095 . . . . 4.0599999999999996 110.989 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.443 ' C ' ' SG ' ' A' ' 81' ' ' CYS . 27.1 p -140.46 179.12 6.85 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.136 -0.977 . . . . 1.0700000000000001 111.183 -179.495 59.787 74.201 119.716 104.185 2.02 105.075 -53.208 -60.027 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -121.21 116.7 25.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.731 -0.606 . . . . 2.6600000000000001 109.579 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.44 ' CG ' ' HB2' ' A' ' 81' ' ' CYS . 0.2 OUTLIER -66.96 -33.61 75.94 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.556 -0.715 . . . . 2.8100000000000001 110.75 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 165.15 -62.45 0.23 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.025 -1.23 . . . . 2.04 110.025 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -115.66 39.66 2.95 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.448 -1.031 . . . . 5.6299999999999999 111.116 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.6 m -100.59 109.67 58.1 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.223 -0.923 . . . . 1.54 109.554 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.07 -37.43 6.12 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 O-C-N 123.831 1.437 . . . . 2.23 111.504 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.45 -25.55 72.63 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.551 -1.019 . . . . 1.8100000000000001 110.551 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . . . -46.03 117.97 1.71 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.668 -0.901 . . . . 1.4299999999999999 111.844 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.7 p -86.86 -11.02 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.682 -0.636 . . . . 2.21 110.634 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.5 m120 59.59 46.34 12.1 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.686 -0.634 . . . . 2.7999999999999998 111.323 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.14 -50.11 69.49 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.328 -0.857 . . . . 1.3400000000000001 109.045 178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . 0.408 ' HB3' HD22 ' A' ' 79' ' ' LEU . 58.5 m -71.7 -21.65 61.75 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.659 -0.651 . . . . 1.1299999999999999 109.637 178.236 -54.802 -179.656 64.782 103.999 2.024 104.774 33.106 -167.416 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 63.82 61.14 0.99 Allowed 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.389 0.614 . . . . 4.3099999999999996 110.821 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.484 HD22 ' HB2' ' A' ' 95' ' ' CYS . 2.9 pp -163.12 -169.06 1.9 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.579 -0.701 . . . . 2.1099999999999999 110.498 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 32.0 t -99.62 127.47 45.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.554 -0.716 . . . . 1.73 109.925 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.443 ' SG ' ' C ' ' A' ' 65' ' ' CYS . 82.8 m -59.15 -32.98 70.37 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.734 -0.604 . . . . 1.03 109.659 179.384 -60.027 -53.208 119.716 105.075 2.02 104.185 74.201 59.787 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' A' ' 86' ' ' GLN . 47.1 t -56.77 -41.21 77.25 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.635 -0.666 . . . . 1.8600000000000001 110.264 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.12 -29.39 68.59 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.494 -0.754 . . . . 1.1499999999999999 110.79 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.434 ' O ' ' HA2' ' A' ' 55' ' ' GLY . 74.4 mt -62.66 -33.45 75.07 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.389 -0.819 . . . . 1.3100000000000001 110.42 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.495 ' HA ' ' O ' ' A' ' 40' ' ' THR . 0.2 OUTLIER -88.25 -16.05 34.21 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.412 -0.805 . . . . 2.0 110.151 179.355 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 82' ' ' SER . 41.5 mt-30 -66.79 165.82 14.42 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.521 -0.737 . . . . 0.56999999999999995 110.492 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -57.92 -35.47 71.11 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.534 -0.729 . . . . 1.6899999999999999 110.894 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -62.98 120.54 11.58 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.336 -0.853 . . . . 0.87 110.052 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.427 HG21 HD13 ' A' ' 89' ' ' ILE . 46.1 pt -86.96 -10.78 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.567 -0.708 . . . . 1.1299999999999999 111.293 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -51.07 -44.73 61.22 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.416 -0.802 . . . . 1.1200000000000001 111.058 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -67.7 -43.77 79.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.213 -0.93 . . . . 1.8500000000000001 109.833 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.42 ' HA ' HD23 ' A' ' 84' ' ' LEU . . . -60.68 -43.36 97.8 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.451 -0.781 . . . . 1.1499999999999999 109.553 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.459 HG23 ' HG ' ' A' ' 15' ' ' LEU . 49.9 t -71.23 -50.21 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.778 -0.576 . . . . 1.22 109.849 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.41 -39.48 73.09 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.502 -0.749 . . . . 1.1599999999999999 110.629 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' CYS . . . . . 0.532 ' SG ' HG23 ' A' ' 59' ' ' ILE . 16.8 t -78.3 -37.5 44.63 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.402 -0.811 . . . . 0.79000000000000004 109.688 179.231 -167.416 33.106 64.782 104.774 2.024 103.999 -179.656 -54.802 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.55 -45.68 92.99 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.904 -0.776 . . . . 1.24 108.904 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 93' ' ' VAL . 35.1 mtpt -54.23 -48.37 71.17 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.778 -0.453 . . . . 2.3500000000000001 109.778 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -58.12 -35.79 71.99 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.691 -0.63 . . . . 3.5099999999999998 110.579 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.403 ' HA ' ' CH2' ' A' ' 64' ' ' TRP . 84.7 t -66.67 -42.73 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.528 -0.733 . . . . 1.4199999999999999 110.141 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.472 HG11 ' CZ2' ' A' ' 28' ' ' TRP . 32.2 m -82.81 -19.01 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.625 -0.672 . . . . 1.3100000000000001 110.494 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.504 ' HA ' ' HD3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -62.44 -19.14 63.19 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.462 -0.774 . . . . 2.8199999999999998 110.182 178.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.723 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 55.1 m-20 -74.14 175.72 3.5 Favored Pre-proline 0 N--CA 1.5 2.07 0 O-C-N 121.616 -0.677 . . . . 2.3900000000000001 110.255 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.723 ' HD2' ' HB3' ' A' ' 102' ' ' ASP . 40.0 Cg_endo -65.71 -22.38 57.44 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 O-C-N 123.512 1.269 . . . . 1.4199999999999999 111.281 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -71.35 -42.23 68.76 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.196 -0.94 . . . . 2.3500000000000001 109.875 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.52 -131.05 10.11 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.92 -1.272 . . . . 1.1000000000000001 109.92 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.444 ' HB ' HD13 ' A' ' 23' ' ' ILE . 10.7 tp -90.01 30.17 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.639 -0.918 . . . . 2.3999999999999999 110.768 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -112.48 19.97 17.07 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.173 -0.954 . . . . 5.29 110.638 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.61 -40.87 69.54 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.24 -0.913 . . . . 1.73 110.257 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.542 ' CZ2' ' HB3' ' A' ' 58' ' ' GLN . 16.5 m95 -93.14 137.34 32.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.526 -0.734 . . . . 4.9100000000000001 110.319 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.4 p -69.14 -29.16 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.708 -0.62 . . . . 2.1400000000000001 110.952 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.9 -24.7 64.51 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.434 -0.791 . . . . 1.3899999999999999 110.611 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.538 ' HB2' HD11 ' A' ' 31' ' ' LEU . 64.6 t90 -72.71 -42.82 63.75 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.294 -0.879 . . . . 4.6600000000000001 110.036 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.403 ' HA ' ' HB2' ' A' ' 117' ' ' GLN . 5.5 ptp180 -87.42 3.69 46.14 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.398 -0.814 . . . . 3.3100000000000001 111.166 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -99.91 -37.48 9.02 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.183 -0.948 . . . . 1.9199999999999999 109.533 178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -122.82 -5.51 8.56 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.657 -0.652 . . . . 3.8100000000000001 111.434 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 4.2 m -139.72 16.44 2.51 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.938 -1.101 . . . . 1.5800000000000001 111.857 -179.464 -86.932 -157.114 170.747 104.098 2.02 104.058 121.021 91.668 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.403 ' HB2' ' HA ' ' A' ' 113' ' ' ARG . 5.5 tt0 -60.14 96.68 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.108 -0.995 . . . . 2.7400000000000002 110.09 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 50.63 39.63 21.96 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.701 -0.625 . . . . 3.7599999999999998 110.494 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.79 168.03 10.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.384 -0.823 . . . . 4.0700000000000003 110.603 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -74.58 89.03 2.19 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.555 -0.716 . . . . 2.98 109.748 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.447 HG21 ' HA ' ' A' ' 27' ' ' ASN . 27.0 m -108.04 16.37 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.517 -0.739 . . . . 1.3100000000000001 110.643 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.542 ' HA ' ' HB3' ' A' ' 26' ' ' ALA . 4.2 mtp180 -65.93 -32.19 73.54 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.303 -0.873 . . . . 4.1200000000000001 110.915 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -60.68 -24.26 65.48 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.605 -0.684 . . . . 2.6899999999999999 111.733 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.664 ' HB3' ' HE1' ' A' ' 29' ' ' MET . 39.4 m-85 -61.8 -41.15 97.39 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.208 -0.933 . . . . 3.2599999999999998 110.778 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.554 HG11 ' HB3' ' A' ' 25' ' ' LEU . 35.2 m -103.4 -22.18 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.415 -0.803 . . . . 2.46 111.266 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -73.33 115.99 13.35 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.216 -0.928 . . . . 3.8700000000000001 110.334 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 92.51 44.06 4.09 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.375 -1.09 . . . . 2.77 110.375 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 34.1 t -100.3 -39.22 8.12 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.42 -1.047 . . . . 1.9299999999999999 110.261 179.366 -170.711 29.23 163.603 105.062 2.024 104.246 -45.201 -128.037 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.14 46.38 1.09 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.147 -1.581 . . . . 2.71 109.147 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 45.5 t . . . . . 0 N--CA 1.497 1.892 0 O-C-N 121.594 -0.945 . . . . 3.0899999999999999 110.088 -179.72 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.437 ' HD3' ' CE2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 120.969 0.414 . . . . 2.73 110.551 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.549 HG22 ' CG ' ' A' ' 39' ' ' ASN . 45.4 t -80.32 87.0 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.49 -0.756 . . . . 1.8500000000000001 109.474 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.594 ' CG ' ' HG2' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -94.57 -169.38 2.02 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.368 -0.832 . . . . 2.5499999999999998 110.735 -179.673 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -100.63 -172.04 2.12 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.494 -0.754 . . . . 2.0600000000000001 111.388 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.589 ' HG2' ' HE1' ' A' ' 29' ' ' MET . 4.3 ttp180 -72.13 -47.35 51.76 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.643 -0.661 . . . . 2.7999999999999998 111.485 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.61 -36.2 78.03 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.402 -0.811 . . . . 1.04 111.298 -179.047 -128.037 -45.201 163.603 104.246 2.024 105.062 29.23 -170.711 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.594 ' HG2' ' CG ' ' A' ' 3' ' ' PHE . 8.1 tp10 -60.17 -44.53 94.95 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.293 -0.88 . . . . 2.6499999999999999 109.497 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.654 HD21 HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -56.15 -39.05 71.7 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.881 -0.512 . . . . 0.48999999999999999 110.166 179.301 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.757 ' HB2' ' SD ' ' A' ' 29' ' ' MET . . . -58.64 -50.89 72.19 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.43 -0.794 . . . . 0.47999999999999998 110.306 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.684 ' HG3' HG22 ' A' ' 130' ' ' VAL . 7.7 mtp180 -73.51 -31.52 63.75 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.535 -0.728 . . . . 3.2400000000000002 110.481 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.775 HG23 HD13 ' A' ' 89' ' ' ILE . 1.8 m -60.03 -48.93 79.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.611 -0.681 . . . . 1.1599999999999999 109.91 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.622 ' HB2' HD11 ' A' ' 25' ' ' LEU . 86.6 mt -72.61 -33.61 66.81 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.486 -0.759 . . . . 0.48999999999999999 109.863 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.55 ' HD2' HG11 ' A' ' 130' ' ' VAL . 2.7 tttm -67.4 -37.98 83.95 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.397 -0.814 . . . . 2.79 109.644 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 -62.7 -35.64 80.36 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.682 -0.637 . . . . 1.95 109.831 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.845 ' HG ' HG21 ' A' ' 93' ' ' VAL . 1.4 mm? -79.43 -30.82 42.43 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.689 -0.632 . . . . 0.64000000000000001 110.323 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.36 13.38 9.83 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.3 -1.12 . . . . 0.69999999999999996 110.3 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.606 ' HE2' HG13 ' A' ' 93' ' ' VAL . 3.4 mmt -78.71 -19.64 51.96 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.137 -1.214 . . . . 2.75 110.84 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.611 ' HB3' HD12 ' A' ' 25' ' ' LEU . 9.5 p-10 -58.02 106.96 0.41 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.452 -0.78 . . . . 2.1800000000000002 110.377 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.4 46.07 21.58 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.434 -1.067 . . . . 0.69999999999999996 110.434 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -108.38 146.24 33.33 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.204 -1.174 . . . . 1.5900000000000001 110.899 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.612 ' HD2' HG23 ' A' ' 100' ' ' VAL . 0.1 OUTLIER 58.72 24.48 12.27 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.94 -0.475 . . . . 2.79 111.923 179.53 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.95 -17.22 47.54 Favored Glycine 0 N--CA 1.495 2.627 0 O-C-N 120.988 -1.07 . . . . 0.89000000000000001 110.767 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.404 HD13 ' HB ' ' A' ' 106' ' ' ILE . 4.6 mt -93.65 156.05 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.089 -1.242 . . . . 0.85999999999999999 109.774 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.9 p -105.82 158.42 16.76 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.591 -0.693 . . . . 1.4399999999999999 110.374 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.622 HD11 ' HB2' ' A' ' 12' ' ' LEU . 0.3 OUTLIER -57.31 -30.81 65.06 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.541 -0.725 . . . . 1.23 110.456 179.4 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.705 ' HB1' ' O ' ' A' ' 121' ' ' VAL . . . -50.36 -44.49 54.67 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.808 -0.557 . . . . 0.59999999999999998 110.224 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.418 ' CG ' HG21 ' A' ' 121' ' ' VAL . 6.2 m-80 -74.35 -32.85 62.93 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.617 -0.677 . . . . 1.76 109.652 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.544 ' CZ2' HG11 ' A' ' 100' ' ' VAL . 18.3 m95 -70.05 -39.65 75.58 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.642 -0.661 . . . . 2.7799999999999998 110.431 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.757 ' SD ' ' HB2' ' A' ' 9' ' ' ALA . 2.3 mtp -74.28 -40.13 62.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.362 -0.836 . . . . 1.5700000000000001 110.823 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.98 -28.99 69.41 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.408 -0.807 . . . . 1.3999999999999999 110.032 179.552 91.668 121.021 170.747 104.058 2.02 104.098 -157.114 -86.932 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.577 HD13 ' HB2' ' A' ' 112' ' ' TRP . 24.6 tp -76.66 -44.77 32.51 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.431 -0.793 . . . . 1.04 109.641 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.15 -26.83 63.19 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.664 -0.647 . . . . 0.67000000000000004 110.656 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.413 ' HB2' ' OH ' ' A' ' 38' ' ' TYR . 21.9 tttt -61.37 -48.62 80.42 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.594 -0.691 . . . . 2.1299999999999999 110.819 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -90.24 -23.14 21.32 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.55 -0.719 . . . . 2.8900000000000001 110.548 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.409 ' HG2' ' HA ' ' A' ' 57' ' ' PHE . 0.9 OUTLIER -69.29 -52.1 30.75 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.49 -0.756 . . . . 2.3199999999999998 110.134 179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.443 ' HB3' ' CB ' ' A' ' 42' ' ' ALA . 61.7 m -141.75 7.08 1.86 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.601 -0.687 . . . . 1.6200000000000001 111.783 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.25 50.65 63.01 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.313 -1.515 . . . . 0.60999999999999999 109.313 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.594 ' HA ' HD11 ' A' ' 56' ' ' ILE . 21.7 m-85 52.77 44.27 30.44 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.884 -0.774 . . . . 2.6299999999999999 110.435 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.549 ' CG ' HG22 ' A' ' 2' ' ' VAL . 43.9 t30 -123.5 120.24 32.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.37 -0.831 . . . . 1.24 110.123 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 14.1 m -75.85 -40.72 54.17 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.458 -0.776 . . . . 0.97999999999999998 109.323 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.3 mtp180 -66.59 -13.97 61.78 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.817 -0.552 . . . . 3.02 111.498 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.443 ' CB ' ' HB3' ' A' ' 36' ' ' SER . . . -58.86 125.43 23.52 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.27 -0.894 . . . . 0.56000000000000005 110.583 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.951 HG22 ' HA ' ' A' ' 54' ' ' TYR . 26.1 p -143.72 136.34 27.18 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.613 -0.679 . . . . 0.90000000000000002 110.445 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.576 ' HB3' ' HB2' ' A' ' 53' ' ' ASP . 2.4 t30 -99.95 160.58 14.21 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.429 -0.794 . . . . 2.1000000000000001 109.638 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.549 ' HA ' HG23 ' A' ' 52' ' ' THR . 7.3 m-85 -117.08 178.35 4.39 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.425 -0.797 . . . . 5.5700000000000003 110.914 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.623 ' HB2' ' HB2' ' A' ' 49' ' ' ASP . 5.2 p30 -134.03 156.41 48.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.691 -0.631 . . . . 2.7000000000000002 110.527 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.14 80.25 1.3 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.526 -0.734 . . . . 3.1099999999999999 110.195 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.9 35.21 25.26 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.31 -1.116 . . . . 2.7799999999999998 110.31 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.623 ' HB2' ' HB2' ' A' ' 46' ' ' ASN . 24.5 m-20 -121.27 -12.52 8.63 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.369 -1.077 . . . . 4.6600000000000001 111.181 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER 60.21 31.05 20.36 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.557 -0.715 . . . . 5.5199999999999996 111.035 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.7 p -136.18 89.35 2.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.456 -0.777 . . . . 2.2000000000000002 109.521 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.549 HG23 ' HA ' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -95.69 128.4 42.54 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.527 -0.733 . . . . 1.6200000000000001 109.84 -179.487 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.576 ' HB2' ' HB3' ' A' ' 44' ' ' ASN . 13.1 m-20 -77.28 127.94 33.46 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.536 -0.727 . . . . 1.4199999999999999 109.983 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.951 ' HA ' HG22 ' A' ' 43' ' ' THR . 4.3 m-85 -134.69 124.2 24.91 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.608 -0.682 . . . . 3.4100000000000001 110.438 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 84' ' ' LEU . . . 121.98 170.12 13.71 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.967 -1.111 . . . . 0.57999999999999996 111.249 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.654 HD11 HD21 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -65.8 -26.58 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.951 -0.734 . . . . 1.5700000000000001 110.891 179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.521 ' CE2' HD23 ' A' ' 31' ' ' LEU . 0.9 OUTLIER -98.36 14.35 28.34 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.301 -0.874 . . . . 2.8799999999999999 111.031 179.722 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.559 ' HG2' ' HB3' ' A' ' 53' ' ' ASP . 0.8 OUTLIER 50.18 81.7 0.06 Allowed 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.523 -0.735 . . . . 2.6099999999999999 110.704 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.58 HG21 ' SG ' ' A' ' 95' ' ' CYS . 9.1 mt -106.65 116.98 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.151 -0.968 . . . . 1.3500000000000001 110.286 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -60.47 153.82 22.22 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.65 -0.656 . . . . 2.48 111.144 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.2 t -95.7 21.85 7.91 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.571 -0.705 . . . . 1.1699999999999999 111.359 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 9.0 ttp180 -115.5 -22.75 9.12 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.957 -1.089 . . . . 3.0600000000000001 111.294 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.94 3.38 4.87 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.969 -1.082 . . . . 3.1299999999999999 111.845 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.533 ' HA ' ' HB3' ' A' ' 76' ' ' ALA . 25.8 m95 -127.97 -53.62 1.31 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.948 -1.095 . . . . 3.1699999999999999 110.989 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.443 ' C ' ' SG ' ' A' ' 81' ' ' CYS . 27.1 p -140.46 179.12 6.85 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.136 -0.977 . . . . 1.0700000000000001 111.183 -179.495 59.787 74.201 119.716 104.185 2.02 105.075 -53.208 -60.027 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -121.21 116.7 25.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.731 -0.606 . . . . 2.3100000000000001 109.579 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.463 ' CG ' ' HB2' ' A' ' 81' ' ' CYS . 0.2 OUTLIER -66.96 -33.61 75.94 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.556 -0.715 . . . . 2.8100000000000001 110.75 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 165.15 -62.45 0.23 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.025 -1.23 . . . . 1.6200000000000001 110.025 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -115.66 39.66 2.95 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.448 -1.031 . . . . 5.29 111.116 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.6 m -100.59 109.67 58.1 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.223 -0.923 . . . . 1.27 109.554 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.07 -37.43 6.12 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 O-C-N 123.831 1.437 . . . . 2.23 111.504 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.45 -25.55 72.63 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.551 -1.019 . . . . 1.3899999999999999 110.551 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . . . -46.03 117.97 1.71 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.668 -0.901 . . . . 1.05 111.844 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.7 p -86.86 -11.02 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.682 -0.636 . . . . 1.5800000000000001 110.634 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.5 m120 59.59 46.34 12.1 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.686 -0.634 . . . . 2.3599999999999999 111.323 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.533 ' HB3' ' HA ' ' A' ' 64' ' ' TRP . . . -64.14 -50.11 69.49 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.328 -0.857 . . . . 0.82999999999999996 109.045 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.586 ' HB3' HD21 ' A' ' 79' ' ' LEU . 58.5 m -71.7 -21.65 61.75 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.659 -0.651 . . . . 1.1299999999999999 109.637 178.236 -54.802 -179.656 64.782 103.999 2.024 104.774 33.106 -167.416 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 63.82 61.14 0.99 Allowed 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.389 0.614 . . . . 3.3900000000000001 110.821 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.586 HD21 ' HB3' ' A' ' 77' ' ' CYS . 2.9 pp -163.12 -169.06 1.9 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.579 -0.701 . . . . 1.5700000000000001 110.498 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 32.0 t -99.62 127.47 45.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.554 -0.716 . . . . 1.3799999999999999 109.925 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.463 ' HB2' ' CG ' ' A' ' 67' ' ' ASP . 82.8 m -59.15 -32.98 70.37 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.734 -0.604 . . . . 1.03 109.659 179.384 -60.027 -53.208 119.716 105.075 2.02 104.185 74.201 59.787 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.463 ' HA ' HD23 ' A' ' 85' ' ' LEU . 47.1 t -56.77 -41.21 77.25 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.635 -0.666 . . . . 1.4299999999999999 110.264 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.12 -29.39 68.59 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.494 -0.754 . . . . 0.46999999999999997 110.79 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.491 HD23 ' HB3' ' A' ' 91' ' ' ASP . 74.4 mt -62.66 -33.45 75.07 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.389 -0.819 . . . . 0.63 110.42 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.52 ' HA ' ' O ' ' A' ' 40' ' ' THR . 0.2 OUTLIER -88.25 -16.05 34.21 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.412 -0.805 . . . . 1.49 110.151 179.355 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 82' ' ' SER . 41.5 mt-30 -66.79 165.82 14.42 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.521 -0.737 . . . . 0.53000000000000003 110.492 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -57.92 -35.47 71.11 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.534 -0.729 . . . . 1.6899999999999999 110.894 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -62.98 120.54 11.58 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.336 -0.853 . . . . 0.87 110.052 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.775 HD13 HG23 ' A' ' 11' ' ' THR . 46.1 pt -86.96 -10.78 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.567 -0.708 . . . . 0.37 111.293 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -51.07 -44.73 61.22 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.416 -0.802 . . . . 0.47999999999999998 111.058 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.491 ' HB3' HD23 ' A' ' 84' ' ' LEU . 9.1 m-20 -67.7 -43.77 79.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.213 -0.93 . . . . 1.8500000000000001 109.833 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.442 ' HA ' HD22 ' A' ' 84' ' ' LEU . . . -60.68 -43.36 97.8 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.451 -0.781 . . . . 0.62 109.553 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.845 HG21 ' HG ' ' A' ' 15' ' ' LEU . 49.9 t -71.23 -50.21 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.778 -0.576 . . . . 0.55000000000000004 109.849 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.41 -39.48 73.09 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.502 -0.749 . . . . 0.54000000000000004 110.629 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' CYS . . . . . 0.58 ' SG ' HG21 ' A' ' 59' ' ' ILE . 16.8 t -78.3 -37.5 44.63 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.402 -0.811 . . . . 0.75 109.688 179.231 -167.416 33.106 64.782 104.774 2.024 103.999 -179.656 -54.802 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.55 -45.68 92.99 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.904 -0.776 . . . . 0.65000000000000002 108.904 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 93' ' ' VAL . 35.1 mtpt -54.23 -48.37 71.17 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.778 -0.453 . . . . 1.9099999999999999 109.778 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -58.12 -35.79 71.99 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.691 -0.63 . . . . 2.9399999999999999 110.579 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 95' ' ' CYS . 84.7 t -66.67 -42.73 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.528 -0.733 . . . . 0.76000000000000001 110.141 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.612 HG23 ' HD2' ' A' ' 21' ' ' ARG . 32.2 m -82.81 -19.01 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.625 -0.672 . . . . 0.79000000000000004 110.494 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.511 ' HA ' ' HD3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -62.44 -19.14 63.19 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.462 -0.774 . . . . 2.4100000000000001 110.182 178.688 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.734 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 55.1 m-20 -74.14 175.72 3.5 Favored Pre-proline 0 N--CA 1.5 2.07 0 O-C-N 121.616 -0.677 . . . . 2.3900000000000001 110.255 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.734 ' HD2' ' HB3' ' A' ' 102' ' ' ASP . 40.0 Cg_endo -65.71 -22.38 57.44 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 O-C-N 123.512 1.269 . . . . 1.3 111.281 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -71.35 -42.23 68.76 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.196 -0.94 . . . . 2.3500000000000001 109.875 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.52 -131.05 10.11 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.92 -1.272 . . . . 1.0 109.92 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.404 ' HB ' HD13 ' A' ' 23' ' ' ILE . 10.7 tp -90.01 30.17 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.639 -0.918 . . . . 1.9399999999999999 110.768 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -112.48 19.97 17.07 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.173 -0.954 . . . . 4.5099999999999998 110.638 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.61 -40.87 69.54 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.24 -0.913 . . . . 1.2 110.257 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.559 ' CZ2' ' HB3' ' A' ' 58' ' ' GLN . 16.5 m95 -93.14 137.34 32.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.526 -0.734 . . . . 4.0199999999999996 110.319 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.468 HG22 ' OD1' ' A' ' 114' ' ' ASN . 4.4 p -69.14 -29.16 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.708 -0.62 . . . . 1.6100000000000001 110.952 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.9 -24.7 64.51 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.434 -0.791 . . . . 0.82999999999999996 110.611 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.577 ' HB2' HD13 ' A' ' 31' ' ' LEU . 64.6 t90 -72.71 -42.82 63.75 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.294 -0.879 . . . . 3.8100000000000001 110.036 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.443 ' HA ' ' HB2' ' A' ' 117' ' ' GLN . 5.5 ptp180 -87.42 3.69 46.14 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.398 -0.814 . . . . 2.6400000000000001 111.166 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.468 ' OD1' HG22 ' A' ' 110' ' ' VAL . 1.7 m120 -99.91 -37.48 9.02 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.183 -0.948 . . . . 1.9199999999999999 109.533 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -122.82 -5.51 8.56 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.657 -0.652 . . . . 3.1400000000000001 111.434 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 4.2 m -139.72 16.44 2.51 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.938 -1.101 . . . . 1.4299999999999999 111.857 -179.464 -86.932 -157.114 170.747 104.098 2.02 104.058 121.021 91.668 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.443 ' HB2' ' HA ' ' A' ' 113' ' ' ARG . 5.5 tt0 -60.14 96.68 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.108 -0.995 . . . . 2.6699999999999999 110.09 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 50.63 39.63 21.96 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.701 -0.625 . . . . 3.0299999999999998 110.494 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.79 168.03 10.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.384 -0.823 . . . . 3.4900000000000002 110.603 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -74.58 89.03 2.19 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.555 -0.716 . . . . 2.98 109.748 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.705 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 27.0 m -108.04 16.37 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.517 -0.739 . . . . 0.89000000000000001 110.643 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -65.93 -32.19 73.54 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.303 -0.873 . . . . 3.5499999999999998 110.915 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -60.68 -24.26 65.48 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.605 -0.684 . . . . 2.1099999999999999 111.733 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.688 ' HB3' ' HE2' ' A' ' 29' ' ' MET . 39.4 m-85 -61.8 -41.15 97.39 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.208 -0.933 . . . . 2.7999999999999998 110.778 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.576 HG11 ' HB3' ' A' ' 25' ' ' LEU . 35.2 m -103.4 -22.18 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.415 -0.803 . . . . 1.8899999999999999 111.266 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -73.33 115.99 13.35 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.216 -0.928 . . . . 3.1899999999999999 110.334 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 92.51 44.06 4.09 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.375 -1.09 . . . . 2.1200000000000001 110.375 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 34.1 t -100.3 -39.22 8.12 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.42 -1.047 . . . . 1.9299999999999999 110.261 179.366 -170.711 29.23 163.603 105.062 2.024 104.246 -45.201 -128.037 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.14 46.38 1.09 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.147 -1.581 . . . . 2.71 109.147 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.684 HG22 ' HG3' ' A' ' 10' ' ' ARG . 45.5 t . . . . . 0 N--CA 1.497 1.892 0 O-C-N 121.594 -0.945 . . . . 3.0 110.088 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.437 ' HD3' ' CE2' ' A' ' 3' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 120.969 0.414 . . . . 2.73 110.551 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.549 HG22 ' CG ' ' A' ' 39' ' ' ASN . 45.4 t -80.32 87.0 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.49 -0.756 . . . . 1.85 109.474 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.594 ' CG ' ' HG2' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -94.57 -169.38 2.02 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.368 -0.832 . . . . 2.55 110.735 -179.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -100.63 -172.04 2.12 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.494 -0.754 . . . . 2.06 111.388 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.589 ' HG2' ' HE1' ' A' ' 29' ' ' MET . 4.3 ttp180 -72.13 -47.35 51.76 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.643 -0.661 . . . . 2.8 111.485 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.61 -36.2 78.03 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.402 -0.811 . . . . 1.04 111.298 -179.047 -128.037 -45.201 163.603 104.246 2.024 105.062 29.23 -170.711 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.594 ' HG2' ' CG ' ' A' ' 3' ' ' PHE . 8.1 tp10 -60.17 -44.53 94.95 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.293 -0.88 . . . . 2.65 109.497 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.654 HD21 HD11 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -56.15 -39.05 71.7 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.881 -0.512 . . . . 0.49 110.166 179.301 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.757 ' HB2' ' SD ' ' A' ' 29' ' ' MET . . . -58.64 -50.89 72.19 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.43 -0.794 . . . . 0.48 110.306 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.684 ' HG3' HG22 ' A' ' 130' ' ' VAL . 7.7 mtp180 -73.51 -31.52 63.75 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.535 -0.728 . . . . 3.24 110.481 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.775 HG23 HD13 ' A' ' 89' ' ' ILE . 1.8 m -60.03 -48.93 79.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.611 -0.681 . . . . 1.16 109.91 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.622 ' HB2' HD11 ' A' ' 25' ' ' LEU . 86.6 mt -72.61 -33.61 66.81 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.486 -0.759 . . . . 0.49 109.863 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.55 ' HD2' HG11 ' A' ' 130' ' ' VAL . 2.7 tttm -67.4 -37.98 83.95 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.397 -0.814 . . . . 2.79 109.644 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 27.3 mtm180 -62.7 -35.64 80.36 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.682 -0.637 . . . . 1.95 109.831 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.845 ' HG ' HG21 ' A' ' 93' ' ' VAL . 1.4 mm? -79.43 -30.82 42.43 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.689 -0.632 . . . . 0.64 110.323 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.36 13.38 9.83 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.3 -1.12 . . . . 0.7 110.3 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.606 ' HE2' HG13 ' A' ' 93' ' ' VAL . 3.4 mmt -78.71 -19.64 51.96 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.137 -1.214 . . . . 2.75 110.84 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.611 ' HB3' HD12 ' A' ' 25' ' ' LEU . 9.5 p-10 -58.02 106.96 0.41 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.452 -0.78 . . . . 2.18 110.377 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.4 46.07 21.58 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.434 -1.067 . . . . 0.7 110.434 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -108.38 146.24 33.33 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.204 -1.174 . . . . 1.59 110.899 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.612 ' HD2' HG23 ' A' ' 100' ' ' VAL . 0.1 OUTLIER 58.72 24.48 12.27 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.94 -0.475 . . . . 2.79 111.923 179.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.95 -17.22 47.54 Favored Glycine 0 N--CA 1.495 2.627 0 O-C-N 120.988 -1.07 . . . . 0.89 110.767 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.404 HD13 ' HB ' ' A' ' 106' ' ' ILE . 4.6 mt -93.65 156.05 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.089 -1.242 . . . . 0.86 109.774 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 89.9 p -105.82 158.42 16.76 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.591 -0.693 . . . . 1.44 110.374 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.622 HD11 ' HB2' ' A' ' 12' ' ' LEU . 0.3 OUTLIER -57.31 -30.81 65.06 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.541 -0.725 . . . . 1.23 110.456 179.4 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.705 ' HB1' ' O ' ' A' ' 121' ' ' VAL . . . -50.36 -44.49 54.67 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.808 -0.557 . . . . 0.6 110.224 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.418 ' CG ' HG21 ' A' ' 121' ' ' VAL . 1.6 m120 -74.35 -32.85 62.93 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.617 -0.677 . . . . 1.76 109.652 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.544 ' CZ2' HG11 ' A' ' 100' ' ' VAL . 18.3 m95 -70.05 -39.65 75.58 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.642 -0.661 . . . . 2.78 110.431 179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.757 ' SD ' ' HB2' ' A' ' 9' ' ' ALA . 2.3 mtp -74.28 -40.13 62.5 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.362 -0.836 . . . . 1.57 110.823 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.98 -28.99 69.41 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.408 -0.807 . . . . 1.4 110.032 179.552 91.668 121.021 170.747 104.058 2.02 104.098 -157.114 -86.932 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.577 HD13 ' HB2' ' A' ' 112' ' ' TRP . 24.6 tp -76.66 -44.77 32.51 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.431 -0.793 . . . . 1.04 109.641 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.15 -26.83 63.19 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.664 -0.647 . . . . 0.67 110.656 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.413 ' HB2' ' OH ' ' A' ' 38' ' ' TYR . 21.9 tttt -61.37 -48.62 80.42 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.594 -0.691 . . . . 2.13 110.819 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -90.24 -23.14 21.32 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.55 -0.719 . . . . 2.89 110.548 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.409 ' HG2' ' HA ' ' A' ' 57' ' ' PHE . 0.9 OUTLIER -69.29 -52.1 30.75 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.49 -0.756 . . . . 2.32 110.134 179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.443 ' HB3' ' CB ' ' A' ' 42' ' ' ALA . 61.7 m -141.75 7.08 1.86 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.601 -0.687 . . . . 1.62 111.783 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.25 50.65 63.01 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 109.313 -1.515 . . . . 0.61 109.313 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.594 ' HA ' HD11 ' A' ' 56' ' ' ILE . 21.7 m-85 52.77 44.27 30.44 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.884 -0.774 . . . . 2.63 110.435 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.549 ' CG ' HG22 ' A' ' 2' ' ' VAL . 43.9 t30 -123.5 120.24 32.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.37 -0.831 . . . . 1.24 110.123 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.52 ' O ' ' HA ' ' A' ' 85' ' ' LEU . 14.1 m -75.85 -40.72 54.17 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.458 -0.776 . . . . 0.98 109.323 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.3 mtp180 -66.59 -13.97 61.78 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.817 -0.552 . . . . 3.02 111.498 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.443 ' CB ' ' HB3' ' A' ' 36' ' ' SER . . . -58.86 125.43 23.52 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.27 -0.894 . . . . 0.56 110.583 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.951 HG22 ' HA ' ' A' ' 54' ' ' TYR . 26.1 p -143.72 136.34 27.18 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.613 -0.679 . . . . 0.9 110.445 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.576 ' HB3' ' HB2' ' A' ' 53' ' ' ASP . 2.4 t30 -99.95 160.58 14.21 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.429 -0.794 . . . . 2.1 109.638 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.549 ' HA ' HG23 ' A' ' 52' ' ' THR . 7.3 m-85 -117.08 178.35 4.39 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.425 -0.797 . . . . 5.57 110.914 -179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.623 ' HB2' ' HB2' ' A' ' 49' ' ' ASP . 5.2 p30 -134.03 156.41 48.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.691 -0.631 . . . . 2.7 110.527 -179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -109.14 80.25 1.3 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.526 -0.734 . . . . 3.11 110.195 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 80.9 35.21 25.26 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.31 -1.116 . . . . 2.78 110.31 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.623 ' HB2' ' HB2' ' A' ' 46' ' ' ASN . 24.5 m-20 -121.27 -12.52 8.63 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.369 -1.077 . . . . 4.66 111.181 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER 60.21 31.05 20.36 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.557 -0.715 . . . . 5.52 111.035 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.7 p -136.18 89.35 2.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.456 -0.777 . . . . 2.2 109.521 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.549 HG23 ' HA ' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -95.69 128.4 42.54 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.527 -0.733 . . . . 1.62 109.84 -179.487 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.576 ' HB2' ' HB3' ' A' ' 44' ' ' ASN . 13.1 m-20 -77.28 127.94 33.46 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.536 -0.727 . . . . 1.42 109.983 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.951 ' HA ' HG22 ' A' ' 43' ' ' THR . 4.3 m-85 -134.69 124.2 24.91 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.608 -0.682 . . . . 3.41 110.438 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 84' ' ' LEU . . . 121.98 170.12 13.71 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.967 -1.111 . . . . 0.58 111.249 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.654 HD11 HD21 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -65.8 -26.58 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 O-C-N 121.951 -0.734 . . . . 1.57 110.891 179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.521 ' CE2' HD23 ' A' ' 31' ' ' LEU . 0.9 OUTLIER -98.36 14.35 28.34 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.301 -0.874 . . . . 2.88 111.031 179.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.559 ' HG2' ' HB3' ' A' ' 53' ' ' ASP . 0.8 OUTLIER 50.18 81.7 0.06 Allowed 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.523 -0.735 . . . . 2.61 110.704 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.58 HG21 ' SG ' ' A' ' 95' ' ' CYS . 9.1 mt -106.65 116.98 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.151 -0.968 . . . . 1.35 110.286 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -60.47 153.82 22.22 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.65 -0.656 . . . . 2.48 111.144 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.2 t -95.7 21.85 7.91 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.571 -0.705 . . . . 1.17 111.359 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 73' ' ' ALA . 9.0 ttp180 -115.5 -22.75 9.12 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.957 -1.089 . . . . 3.06 111.294 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.94 3.38 4.87 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.969 -1.082 . . . . 3.13 111.845 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.533 ' HA ' ' HB3' ' A' ' 76' ' ' ALA . 25.8 m95 -127.97 -53.62 1.31 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.948 -1.095 . . . . 3.17 110.989 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.443 ' C ' ' SG ' ' A' ' 81' ' ' CYS . 27.1 p -140.46 179.12 6.85 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.136 -0.977 . . . . 1.07 111.183 -179.495 59.787 74.201 119.716 104.185 2.02 105.075 -53.208 -60.027 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -121.21 116.7 25.42 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.731 -0.606 . . . . 2.31 109.579 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.463 ' CG ' ' HB2' ' A' ' 81' ' ' CYS . 0.2 OUTLIER -66.96 -33.61 75.94 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.556 -0.715 . . . . 2.81 110.75 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 165.15 -62.45 0.23 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.025 -1.23 . . . . 1.62 110.025 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -115.66 39.66 2.95 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.448 -1.031 . . . . 5.29 111.116 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.6 m -100.59 109.67 58.1 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 121.223 -0.923 . . . . 1.27 109.554 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.07 -37.43 6.12 Favored 'Trans proline' 0 N--CA 1.49 1.319 0 O-C-N 123.831 1.437 . . . . 2.23 111.504 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -66.45 -25.55 72.63 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.551 -1.019 . . . . 1.39 110.551 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.48 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . . . -46.03 117.97 1.71 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.668 -0.901 . . . . 1.05 111.844 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.7 p -86.86 -11.02 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.682 -0.636 . . . . 1.58 110.634 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.5 m120 59.59 46.34 12.1 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.686 -0.634 . . . . 2.36 111.323 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.533 ' HB3' ' HA ' ' A' ' 64' ' ' TRP . . . -64.14 -50.11 69.49 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.328 -0.857 . . . . 0.83 109.045 178.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.586 ' HB3' HD21 ' A' ' 79' ' ' LEU . 58.5 m -71.7 -21.65 61.75 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.659 -0.651 . . . . 1.13 109.637 178.236 -54.802 -179.656 64.782 103.999 2.024 104.774 33.106 -167.416 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 63.82 61.14 0.99 Allowed 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 121.389 0.614 . . . . 3.39 110.821 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.586 HD21 ' HB3' ' A' ' 77' ' ' CYS . 2.9 pp -163.12 -169.06 1.9 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.579 -0.701 . . . . 1.57 110.498 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 32.0 t -99.62 127.47 45.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.554 -0.716 . . . . 1.38 109.925 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.463 ' HB2' ' CG ' ' A' ' 67' ' ' ASP . 82.8 m -59.15 -32.98 70.37 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.734 -0.604 . . . . 1.03 109.659 179.384 -60.027 -53.208 119.716 105.075 2.02 104.185 74.201 59.787 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.463 ' HA ' HD23 ' A' ' 85' ' ' LEU . 47.1 t -56.77 -41.21 77.25 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.635 -0.666 . . . . 1.43 110.264 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.12 -29.39 68.59 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.494 -0.754 . . . . 0.47 110.79 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.491 HD23 ' HB3' ' A' ' 91' ' ' ASP . 74.4 mt -62.66 -33.45 75.07 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.389 -0.819 . . . . 0.63 110.42 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.52 ' HA ' ' O ' ' A' ' 40' ' ' THR . 0.2 OUTLIER -88.25 -16.05 34.21 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.412 -0.805 . . . . 1.49 110.151 179.355 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 82' ' ' SER . 41.5 mt-30 -66.79 165.82 14.42 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.521 -0.737 . . . . 0.53 110.492 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -57.92 -35.47 71.11 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.534 -0.729 . . . . 1.69 110.894 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -62.98 120.54 11.58 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.336 -0.853 . . . . 0.87 110.052 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.775 HD13 HG23 ' A' ' 11' ' ' THR . 46.1 pt -86.96 -10.78 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.567 -0.708 . . . . 0.37 111.293 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -51.07 -44.73 61.22 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.416 -0.802 . . . . 0.48 111.058 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.491 ' HB3' HD23 ' A' ' 84' ' ' LEU . 9.1 m-20 -67.7 -43.77 79.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.213 -0.93 . . . . 1.85 109.833 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.442 ' HA ' HD22 ' A' ' 84' ' ' LEU . . . -60.68 -43.36 97.8 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.451 -0.781 . . . . 0.62 109.553 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.845 HG21 ' HG ' ' A' ' 15' ' ' LEU . 49.9 t -71.23 -50.21 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.778 -0.576 . . . . 0.55 109.849 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.41 -39.48 73.09 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.502 -0.749 . . . . 0.54 110.629 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' CYS . . . . . 0.58 ' SG ' HG21 ' A' ' 59' ' ' ILE . 16.8 t -78.3 -37.5 44.63 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.402 -0.811 . . . . 0.75 109.688 179.231 -167.416 33.106 64.782 104.774 2.024 103.999 -179.656 -54.802 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -60.55 -45.68 92.99 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.904 -0.776 . . . . 0.65 108.904 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 93' ' ' VAL . 35.1 mtpt -54.23 -48.37 71.17 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.778 -0.453 . . . . 1.91 109.778 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -58.12 -35.79 71.99 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.691 -0.63 . . . . 2.94 110.579 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 95' ' ' CYS . 84.7 t -66.67 -42.73 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.528 -0.733 . . . . 0.76 110.141 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.612 HG23 ' HD2' ' A' ' 21' ' ' ARG . 32.2 m -82.81 -19.01 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.625 -0.672 . . . . 0.79 110.494 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.511 ' HA ' ' HD3' ' A' ' 21' ' ' ARG . 0.0 OUTLIER -62.44 -19.14 63.19 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.462 -0.774 . . . . 2.41 110.182 178.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.734 ' HB3' ' HD2' ' A' ' 103' ' ' PRO . 55.1 m-20 -74.14 175.72 3.5 Favored Pre-proline 0 N--CA 1.5 2.07 0 O-C-N 121.616 -0.677 . . . . 2.39 110.255 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.734 ' HD2' ' HB3' ' A' ' 102' ' ' ASP . 40.0 Cg_endo -65.71 -22.38 57.44 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 O-C-N 123.512 1.269 . . . . 1.3 111.281 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -71.35 -42.23 68.76 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.196 -0.94 . . . . 2.35 109.875 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 81.52 -131.05 10.11 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.92 -1.272 . . . . 1.0 109.92 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.404 ' HB ' HD13 ' A' ' 23' ' ' ILE . 10.7 tp -90.01 30.17 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.639 -0.918 . . . . 1.94 110.768 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -112.48 19.97 17.07 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.173 -0.954 . . . . 4.51 110.638 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.61 -40.87 69.54 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.24 -0.913 . . . . 1.2 110.257 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.559 ' CZ2' ' HB3' ' A' ' 58' ' ' GLN . 16.5 m95 -93.14 137.34 32.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.526 -0.734 . . . . 4.02 110.319 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.62 HG22 ' ND2' ' A' ' 114' ' ' ASN . 4.4 p -69.14 -29.16 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.708 -0.62 . . . . 1.61 110.952 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.9 -24.7 64.51 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.434 -0.791 . . . . 0.83 110.611 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.577 ' HB2' HD13 ' A' ' 31' ' ' LEU . 64.6 t90 -72.71 -42.82 63.75 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.294 -0.879 . . . . 3.81 110.036 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.443 ' HA ' ' HB2' ' A' ' 117' ' ' GLN . 5.5 ptp180 -87.42 3.69 46.14 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.398 -0.814 . . . . 2.64 111.166 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.62 ' ND2' HG22 ' A' ' 110' ' ' VAL . 1.3 m-80 -99.91 -37.48 9.02 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.183 -0.948 . . . . 1.92 109.533 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -122.82 -5.51 8.56 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.657 -0.652 . . . . 3.14 111.434 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 4.2 m -139.72 16.44 2.51 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.938 -1.101 . . . . 1.43 111.857 -179.464 -86.932 -157.114 170.747 104.098 2.02 104.058 121.021 91.668 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.443 ' HB2' ' HA ' ' A' ' 113' ' ' ARG . 5.5 tt0 -60.14 96.68 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.108 -0.995 . . . . 2.67 110.09 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 50.63 39.63 21.96 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.701 -0.625 . . . . 3.03 110.494 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.79 168.03 10.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.384 -0.823 . . . . 3.49 110.603 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -74.58 89.03 2.19 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.555 -0.716 . . . . 2.98 109.748 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.705 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 27.0 m -108.04 16.37 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.517 -0.739 . . . . 0.89 110.643 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -65.93 -32.19 73.54 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.303 -0.873 . . . . 3.55 110.915 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -60.68 -24.26 65.48 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.605 -0.684 . . . . 2.11 111.733 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.688 ' HB3' ' HE2' ' A' ' 29' ' ' MET . 39.4 m-85 -61.8 -41.15 97.39 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.208 -0.933 . . . . 2.8 110.778 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.576 HG11 ' HB3' ' A' ' 25' ' ' LEU . 35.2 m -103.4 -22.18 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 O-C-N 121.415 -0.803 . . . . 1.89 111.266 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -73.33 115.99 13.35 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.216 -0.928 . . . . 3.19 110.334 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . 92.51 44.06 4.09 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.375 -1.09 . . . . 2.12 110.375 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 34.1 t -100.3 -39.22 8.12 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.42 -1.047 . . . . 1.93 110.261 179.366 -170.711 29.23 163.603 105.062 2.024 104.246 -45.201 -128.037 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 107.14 46.38 1.09 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.147 -1.581 . . . . 2.71 109.147 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.684 HG22 ' HG3' ' A' ' 10' ' ' ARG . 45.5 t . . . . . 0 N--CA 1.497 1.892 0 O-C-N 121.594 -0.945 . . . . 3.0 110.088 -179.72 . . . . . . . . 1 1 . 1 stop_ save_